Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, known as...
Zydus Wellness and its parent Cadila Healthcare will jointly buy Heinz India in a deal worth Rs 4,595 crore.The two companies have signed definitive agreements to buy Heinz India, a subsidiary of Kraf...
Cadila Healthcare along with Zydus Wellness will acquire Heinz India in a deal worth Rs 4,595 crore, a regulatory filing by the company said on Wednesday. The two companies have signed definitive agr...